From Pramila Jayapal <[email protected]>
Subject There’s a way to stop this
Date January 24, 2022 5:11 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
                                                         
                                                               


[1]Pramila Jayapal



The prices of more than 400 prescription drugs have gone UP in 2022.

We know that so many families are already struggling to afford the monthly
prescriptions they need. Congress should be ensuring prescription costs
are going DOWN, not up.

And Democrats can do just that by passing the Build Back Better Act. Build
Back Better drastically reduces the cost of many prescription drugs,
including insulin. This is a critical, common-sense reform that Democrats
have championed in Congress and on the campaign trail.

But special interest groups and Big Pharma are doing everything they can
to stop us from delivering for the people. Big Pharma and corporate PACs
care about profits, not the people impacted by the skyrocketing cost of
prescription medications.

Corporate lobbyists will continue to stop Build Back Better and important
reforms like lowering prescription drugs. We must continue to fight back
and deliver for the people.

[ [link removed] ]Can I
count on you to chip in towards my fight to lower the price of
prescription drugs and deliver for working families? We must pass Build
Back Better, and we’re running out of time — that’s why your help right
now is critical.



[ [link removed] ]Chip in $3



In solidarity,

Pramila


 


Contribute to Pramila Jayapal: [link removed]

This email was sent to [email protected]. Email is the most important way for us to reach you about opportunities to get involved. If you need to remove yourself from our email list, click here to unsubscribe:

You can unsubscribe from this mailing list at any time:
[link removed]


Paid for by Pramila for Congress.
Screenshot of the email generated on import

Message Analysis